Total Payments
$83,056
2024 Payments
$16,886
Companies
8
Transactions
125
Medicare Patients
8,917
Medicare Billing
$173,843
Payment Breakdown by Category
Other$52,930 (63.7%)
Consulting$17,135 (20.6%)
Travel$8,021 (9.7%)
Food & Beverage$4,867 (5.9%)
Education$103.08 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $52,930 | 21 | 63.7% |
| Consulting Fee | $17,135 | 4 | 20.6% |
| Travel and Lodging | $8,021 | 25 | 9.7% |
| Food and Beverage | $4,867 | 73 | 5.9% |
| Education | $103.08 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $51,568 | 44 | $0 (2023) |
| Merck Sharp & Dohme LLC | $16,434 | 14 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $11,103 | 23 | $0 (2024) |
| Abbott Laboratories | $3,450 | 38 | $0 (2024) |
| Janssen Research & Development, LLC | $285.32 | 2 | $0 (2019) |
| CVRx, Inc. | $162.20 | 1 | $0 (2021) |
| Sandoz Inc. | $33.44 | 2 | $0 (2023) |
| United Therapeutics Corporation | $19.40 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $16,886 | 20 | Actelion Pharmaceuticals US, Inc. ($10,596) |
| 2023 | $20,021 | 25 | Merck Sharp & Dohme LLC ($10,186) |
| 2022 | $4,881 | 5 | Bayer HealthCare Pharmaceuticals Inc. ($4,881) |
| 2021 | $5,593 | 8 | Bayer HealthCare Pharmaceuticals Inc. ($5,393) |
| 2020 | $5,672 | 3 | Bayer HealthCare Pharmaceuticals Inc. ($5,655) |
| 2019 | $10,530 | 13 | Bayer HealthCare Pharmaceuticals Inc. ($10,119) |
| 2018 | $16,390 | 25 | Bayer HealthCare Pharmaceuticals Inc. ($15,896) |
| 2017 | $3,083 | 26 | Abbott Laboratories ($2,777) |
All Payment Transactions
125 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $24.74 | General |
| Category: Heart Failure | ||||||
| 09/18/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,050.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/12/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $193.32 | General |
| Category: Cardiology | ||||||
| 09/10/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Travel and Lodging | Cash or cash equivalent | $518.60 | General |
| Category: Cardiology | ||||||
| 09/10/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | Cash or cash equivalent | $33.34 | General |
| Category: Cardiology | ||||||
| 08/28/2024 | Merck Sharp & Dohme LLC | WINREVAIR (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,050.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/27/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Consulting Fee | Cash or cash equivalent | $3,815.00 | General |
| Category: Cardiology | ||||||
| 08/17/2024 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $6.56 | General |
| 08/15/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $45.00 | General |
| Category: Cardiology | ||||||
| 08/15/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Cardiology | ||||||
| 08/14/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Travel and Lodging | In-kind items and services | $256.23 | General |
| Category: Cardiology | ||||||
| 04/11/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $147.77 | General |
| 04/09/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Consulting Fee | Cash or cash equivalent | $4,905.00 | General |
| Category: Cardiology | ||||||
| 04/05/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Travel and Lodging | Cash or cash equivalent | $154.23 | General |
| Category: Cardiology | ||||||
| 04/05/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $60.00 | General |
| Category: Cardiology | ||||||
| 04/05/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Travel and Lodging | Cash or cash equivalent | $36.00 | General |
| Category: Cardiology | ||||||
| 04/05/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | Cash or cash equivalent | $22.63 | General |
| Category: Cardiology | ||||||
| 04/05/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Cardiology | ||||||
| 03/25/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Travel and Lodging | In-kind items and services | $506.97 | General |
| Category: Cardiology | ||||||
| 02/05/2024 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Heart Failure | ||||||
| 10/31/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Heart Failure | ||||||
| 10/11/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,050.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/17/2023 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Heart Failure | ||||||
| 08/16/2023 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,264.00 | General |
| Category: Cardio-pulmonary | ||||||
| 08/05/2023 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $39.01 | General |
| Category: Cardio-pulmonary | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 3,088 | 4,481 | $251,016 | $42,700 |
| 2022 | 8 | 2,490 | 3,430 | $195,396 | $34,398 |
| 2021 | 12 | 2,134 | 2,953 | $219,659 | $49,724 |
| 2020 | 12 | 1,205 | 1,572 | $176,059 | $47,021 |
Total Patients
8,917
Total Services
12,436
Medicare Billing
$173,843
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 2,500 | 3,792 | $174,432 | $22,911 | 13.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 52 | 80 | $17,120 | $4,970 | 29.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 46 | $13,067 | $4,225 | 32.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 45 | $8,461 | $2,794 | 33.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 358 | 368 | $16,928 | $2,208 | 13.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 29 | 29 | $5,916 | $1,378 | 23.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 13 | 13 | $3,809 | $1,359 | 35.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $4,030 | $1,326 | 32.9% |
| 93750 | Evaluation of lower heart chamber assist device | Facility | 2023 | 12 | 34 | $4,386 | $984.87 | 22.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 58 | 61 | $2,867 | $544.02 | 19.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 2,066 | 2,934 | $134,964 | $17,424 | 12.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 49 | 86 | $18,404 | $5,917 | 32.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 24 | 41 | $9,676 | $3,163 | 32.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 26 | 39 | $6,435 | $2,180 | 33.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 252 | 256 | $11,776 | $1,444 | 12.3% |
| 93451 | Insertion of tube in right heart chambers for measurement | Facility | 2022 | 13 | 13 | $4,823 | $1,366 | 28.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 11 | 11 | $4,202 | $1,362 | 32.4% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 15 | 15 | $3,471 | $1,183 | 34.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 34 | 35 | $1,645 | $360.65 | 21.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 1,634 | 2,274 | $104,604 | $14,296 | 13.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 56 | 138 | $22,770 | $7,775 | 34.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 60 | 104 | $21,824 | $6,942 | 31.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 22 | 55 | $12,980 | $4,471 | 34.4% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 23 | 23 | $13,386 | $3,681 | 27.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 14 | 26 | $6,994 | $2,577 | 36.8% |
About Dr. Marco Caccamo, DO
Dr. Marco Caccamo, DO is a Cardiovascular Disease healthcare provider based in Morgantown, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2008. The National Provider Identifier (NPI) number assigned to this provider is 1164696530.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Marco Caccamo, DO has received a total of $83,056 in payments from pharmaceutical and medical device companies, with $16,886 received in 2024. These payments were reported across 125 transactions from 8 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($52,930).
As a Medicare-enrolled provider, Caccamo has provided services to 8,917 Medicare beneficiaries, totaling 12,436 services with total Medicare billing of $173,843. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease, Cardiovascular Disease
- Location Morgantown, WV
- Active Since 04/16/2008
- Last Updated 04/08/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1164696530
Products in Payments
- Adempas (Drug) $51,488
- OPSUMIT (Drug) $10,781
- WINREVAIR (Biological) $6,100
- VERQUVO (Drug) $3,050
- Circulatory Support (Device) $2,743
- HeartMate II LVAS (Device) $365.59
- OPSUMIT MACITENTAN (Drug) $286.47
- UPTRAVI (Drug) $224.16
- HeartMate 3 Left Ventricular Dev (Device) $179.71
- Barostim Neo System (Device) $162.20
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $88.68
- HeartMate 3 Left Ventricular Assist Device (Device) $38.40
- AMPLATZER Vascular Plugs (Device) $34.87
- TREPROSTINIL (Drug) $33.44
- ORENITRAM (Drug) $19.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Morgantown
Dr. Wissam Gharib, M. D, M. D
Cardiovascular Disease — Payments: $210,394
Cardiovascular Disease $210,394
Dr. Salam Sbaity, M.d, M.D
Cardiovascular Disease — Payments: $51,550
Cardiovascular Disease $51,550
Dr. Anthony Morise, M. D, M. D
Cardiovascular Disease — Payments: $33,788
Cardiovascular Disease $33,788
Dr. Madhavi Kadiyala, Md, MD
Cardiovascular Disease — Payments: $24,320
Cardiovascular Disease $24,320
David Campsey, Md, MD
Cardiovascular Disease — Payments: $22,060
Cardiovascular Disease $22,060
Dr. Krishna Kishore Bingi, M.d, M.D
Cardiovascular Disease — Payments: $11,955
Cardiovascular Disease $11,955